Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 6129596, 10 pages
https://doi.org/10.1155/2017/6129596
Research Article

Predicting the Remaining Lifespan and Cultivation-Related Loss of Osteogenic Capacity of Bone Marrow Multipotential Stromal Cells Applicable across a Broad Donor Age Range

1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Beckett Street, Leeds LS9 7TF, UK
2NIHR Research Unit, Chapel Allerton Hospital, Leeds Teaching Hospital NHS Trust, Chapeltown Road, Leeds LS7 4SA, UK
3School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK

Correspondence should be addressed to Elena A. Jones; ku.ca.sdeel@jejsm

Received 25 November 2016; Accepted 16 January 2017; Published 19 February 2017

Academic Editor: Krzysztof Marycz

Copyright © 2017 Sarah M. Churchman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. O. C. Oreffo, C. Cooper, C. Mason, and M. Clements, “Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential,” Stem Cell Reviews, vol. 1, no. 2, pp. 169–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Kassem and P. Bianco, “Skeletal stem cells in space and time,” Cell, vol. 160, no. 1-2, pp. 17–19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Li, R. Ghazanfari, D. Zacharaki et al., “Low/negative expression of PDGFR-α identifies the candidate primary mesenchymal stromal cells in adult human bone marrow,” Stem Cell Reports, vol. 3, no. 6, pp. 965–974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. I. Dawson, J. Kanczler, R. Tare, M. Kassem, and R. O. C. Oreffo, “Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies—where are we now?” Stem Cells, vol. 32, no. 1, pp. 35–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Wagner, P. Horn, M. Castoldi et al., “Replicative senescence of mesenchymal stem cells: a continuous and organized process,” PLoS ONE, vol. 3, no. 5, Article ID e2213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Banfi, G. Bianchi, R. Notaro, L. Luzzatto, R. Cancedda, and R. Quarto, “Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells,” Tissue Engineering, vol. 8, no. 6, pp. 901–910, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, “Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies,” Mechanisms of Ageing and Development, vol. 129, no. 3, pp. 163–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Baxter, R. F. Wynn, S. N. Jowitt, J. E. Wraith, L. J. Fairbairn, and I. Bellantuono, “Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion,” Stem Cells, vol. 22, no. 5, pp. 675–682, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Stenderup, J. Justesen, C. Clausen, and M. Kassem, “Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,” Bone, vol. 33, no. 6, pp. 919–926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Wagner, S. Bork, G. Lepperdinger et al., “How to track cellular aging of mesenchymal stromal cells?” Aging, vol. 2, no. 4, pp. 224–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Koch, S. Joussen, A. Schellenberg, Q. Lin, M. Zenke, and W. Wagner, “Monitoring of cellular senescence by DNA-methylation at specific CpG sites,” Aging Cell, vol. 11, no. 2, pp. 366–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Tarte, J. Gaillard, J.-J. Lataillade et al., “Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation,” Blood, vol. 115, no. 8, pp. 1549–1553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Galotto, G. Berisso, L. Delfino et al., “Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients,” Experimental Hematology, vol. 27, no. 9, pp. 1460–1466, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. A. G. Bodnar, M. Ouellette, M. Frolkis et al., “Extension of life-span by introduction of telomerase into normal human cells,” Science, vol. 279, no. 5349, pp. 349–352, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Jones, A. English, S. M. Churchman et al., “Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells,” Arthritis & Rheumatism, vol. 62, no. 7, pp. 1944–1954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Churchman, F. Ponchel, S. A. Boxall et al., “Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and wnt pathway signaling activity,” Arthritis & Rheumatism, vol. 64, no. 8, pp. 2632–2643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Cawthon, “Telomere length measurement by a novel monochrome multiplex quantitative PCR method,” Nucleic Acids Research, vol. 37, no. 3, article e21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Bianchi, A. Banfi, M. Mastrogiacomo et al., “Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2,” Experimental Cell Research, vol. 287, no. 1, pp. 98–105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Chen and G. Q. Daley, “Molecular basis of pluripotency,” Human Molecular Genetics, vol. 17, no. 1, pp. R23–R27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Harichandan and H.-J. Bühring, “Prospective isolation of human MSC,” Best Practice & Research Clinical Haematology, vol. 24, no. 1, pp. 25–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Siegel, T. Kluba, U. Hermanutz-Klein, K. Bieback, H. Northoff, and R. Schäfer, “Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells,” BMC Medicine, vol. 11, no. 1, article 146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Cawthon, “Telomere measurement by quantitative PCR,” Nucleic Acids Research, vol. 30, no. 10, article e47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Spees, R. H. Lee, and C. A. Gregory, “Mechanisms of mesenchymal stem/stromal cell function,” Stem Cell Research & Therapy, vol. 7, no. 1, article 125, 2016. View at Publisher · View at Google Scholar
  25. P. Hernigou, A. Poignard, F. Beaujean, and H. Rouard, “Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells,” The Journal of Bone & Joint Surgery—American Volume, vol. 87, no. 7, pp. 1430–1437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Wagner, S. Bork, P. Horn et al., “Aging and replicative senescence have related effects on human stem and progenitor cells,” PLoS ONE, vol. 4, no. 6, Article ID e5846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Schallmoser, C. Bartmann, E. Rohde et al., “Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions,” Haematologica, vol. 95, no. 6, pp. 867–874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Tanabe, Y. Sato, T. Suzuki, K. Suzuki, T. Nagao, and T. Yamaguchi, “Gene expression profiling of human mesenchymal stem cells for identification of novel markers in early- and late-stage cell culture,” Journal of Biochemistry, vol. 144, no. 3, pp. 399–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. De Bari, F. Dell'Accio, A. Karystinou et al., “A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells,” Arthritis & Rheumatism, vol. 58, no. 1, pp. 240–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Tormin, O. Li, J. C. Brune et al., “CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization,” Blood, vol. 117, no. 19, pp. 5067–5077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Qian, K. Le Blanc, and M. Sigvardsson, “Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein,” The Journal of Biological Chemistry, vol. 287, no. 31, pp. 25795–25807, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Isenmann, A. Arthur, A. C. W. Zannettino et al., “TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment,” Stem Cells, vol. 27, no. 10, pp. 2457–2468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Go, C. Takenaka, and H. Ohgushi, “Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities,” Experimental Cell Research, vol. 314, no. 5, pp. 1147–1154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. W. L. Lambiv, I. Vassallo, M. Delorenzi et al., “The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence,” Neuro-Oncology, vol. 13, no. 7, pp. 736–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. M. Digirolamo, D. Stokes, D. Colter, D. G. Phinney, R. Class, and D. J. Prockop, “Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate,” British Journal of Haematology, vol. 107, no. 2, pp. 275–281, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Halfon, N. Abramov, B. Grinblat, and I. Ginis, “Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging,” Stem Cells and Development, vol. 20, no. 1, pp. 53–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Satomura, P. Krebsbach, P. Bianco, and P. G. Robey, “Osteogenic imprinting upstream of marrow stromal cell differentiation,” Journal of Cellular Biochemistry, vol. 78, no. 3, pp. 391–403, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Kuçi, J. Seiberth, H. Latifi-Pupovci et al., “Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression,” Haematologica, vol. 98, no. 10, pp. 1609–1616, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. G. Gregory, K. F. Barlow, K. E. McLay et al., “The DNA sequence and biological annotation of human chromosome 1,” Nature, vol. 441, no. 7091, pp. 315–321, 2006. View at Publisher · View at Google Scholar
  40. D. L. Coutu, M. François, and J. Galipeau, “Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells,” Blood, vol. 117, no. 25, pp. 6801–6812, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Murgia, E. Veronesi, O. Candini et al., “Potency biomarker signature genes from multiparametric osteogenesis assays: will cGMP human bone marrow mesenchymal stromal cells make bone?” PLoS ONE, vol. 11, no. 10, Article ID e0163629, 2016. View at Publisher · View at Google Scholar